3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Gynecologic
1
Dermatologic
1
Conditions
Warts
2
Melanoma
2
Hyperthermia
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Lymphoma, T-Cell
1
Hemorrhage
1
Hematologic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
8
Biopsy
8
Specimen Handling
7
Magnetic Resonance Spectroscopy
6
fludarabine
5
ruxolitinib
4
Vincristine
4
X-Rays
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Cytarabine
3
10-propargyl-10-deazaaminopterin
3
sodium-iodide symporter
2
pembrolizumab
2
duvelisib
2
cemiplimab
2
Prednisone
2
Photons
2
Methotrexate
2
Immunoglobulin G
2
Hydrocortisone
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Doxorubicin
2
Disulfides
2
Dexamethasone
2
Calcium Dobesilate
2
Azacitidine
2
venetoclax
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma, T-Cell
×
Solutions
×
Clear all
NCT04752826
2026-02-18
MK-3475-D20
BioInvent International AB
Phase 1/2
Recruiting
176 enrolled